ASRS 2023: Pegcetacoplan Continues Reducing Geographic Atrophy Lesion Growth Over Time
Extension study demonstrates long-term efficacy and safety at 30 months
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.